Webcast

Thinking Long-Term: Data-Driven Decisions about PrEP, Q&A Session 2

Launch Date
07/22/2021
Credit Amount
0.00 Expired
Credit Expires
07/22/2022

Faculty

David Alain Wohl, MD
Professor of Medicine, Institute of Global Health and Infectious Diseases
Site Leader, Global Infectious Diseases Clinical Trials Unit, Chapel Hill Site, The University of North Carolina (UNC) at Chapel Hill School of Medicine
David Alain Wohl, MD

In response to the HIV pandemic, Dr. Wohl has focused his career on optimizing the treatment of HIV infection, including identifying the most effective therapeutic approaches and minimizing the adverse effects of therapy. Cognizant that HIV disproportionately affects the most vulnerable, he has worked to improve HIV care and prevention for often marginalized individuals such as the incarcerated, men who have sex with men, and those living in poverty.

Dr. Wohl is active within the U.S. AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN), and served two terms as a member of the U.S. Department of Health and Human Services (DHHS) Panel on Antiretroviral Guidelines and was recently invited to serve on the DHHS Panel on Opportunistic Infection Guidelines.

As part of the response to the 2013-2016 Ebola outbreak in West Africa, Dr. Wohl led UNC clinical research efforts to test interventions for Ebola Virus Disease in Liberia and now is a principal investigator of a clinical cohort that longitudinally follows Ebola survivors, as well as a study to determine the natural history of Lassa fever.

In addition to his research and administrative activities, Dr. Wohl maintains a large HIV continuity clinic at UNC.

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL
Associate Professor, Department of Family and Community Medicine
Lewis Katz School of Medicine at Temple University, Philadelphia, PA
Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL

Margot Savoy, MD, MPH, FAAFP, FABC, CPE, CMQ, FAAPL is Associate Professor for the Department of Family & Community Medicine at the Lewis Katz School of Medicine at Temple University and Temple University Hospital, and Chief Quality Officer for the Temple Faculty Practice Plan. She is an attending physician at Temple University Hospital (Philadelphia, PA) and Christiana Care Health System (Wilmington, DE). Dr. Savoy graduated from the University of Maryland School of Medicine in 2002, completed Family Medicine Residency Program at the Crozer-Keystone Family Medicine Residency Program (Springfield, PA) in 2005, and graduated from the University of North Carolina Chapel Hill Gillings School of Global Public Health in 2008 with a Master’s degree in Public Health in Public Health Leadership with a focus on Public Health Practice. She is certified by the American Board of Family Medicine, the Certifying Commission in Medical Management, and is a Fellow of the Advisory Board Company.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credits

Statement of Need

When making treatment decisions regarding PrEP, it is important that clinicians consider the long-term impact on bone health, lipids, and renal dysfunction. This includes the need for education on data comparing the safety and efficacy of emtricitabine and tenofovir disoproxil fumarate (F/TDF) and emtricitabine and tenofovir alafenamide (F/TAF) in order to facilitate data-driven decisions about PrEP.

This CME Outfitters webcast will feature expert faculty discussing clinical trial outcomes and how to apply them to treatment decision-making in order to improve clinical knowledge, confidence, and performance for utilizing PrEP.

Learning Objectives

At the end of this CME/CE activity, participants should be able to apply clinical trial outcomes to treatment decision-making, considering long-term impact on bone health, lipids, and renal dysfunction.

The following learning objectives pertain only to those requesting CNE or CPE credit: Describe how to apply clinical trial outcomes to treatment decision-making, considering long-term impact on bone health, lipids, and renal dysfunction.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists.

Credit Information

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Pharmacists/Pharmacy Tech (ACPE) 0.5

This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-21-100-L01-P

ABIM MOC 0.5

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Pediatricians (ABP MOC) 1.5

Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.

Dr. Wohl reports that he receives research support and grants from Gilead Sciences, Inc.; Merck & Co., Inc.; and ViiV Healthcare. He is on the advisory committee for Gilead Sciences, Inc.; Janssen Pharmaceuticals, Inc.; Merck & Co., Inc.; and ViiV Healthcare.

Dr. Savoy has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

  • Maria Glukhovsky, PharmD (planning committee)
  • Jan Perez (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.

WC2-044-072221-47

 

Thinking Long-Term: Data-Driven Decisions about PrEP, Q&A Session 2
Event Date: 07/22/2021